- Advertise
- About OncLive
- Editorial Board
- MJH Life Sciences brands
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
My Treatment Approach: Chronic Lymphocytic Leukemia | Supplements and Featured Publications
An Expert Provides Insight Into the Use of BTK Inhibitors in CLL
June 15, 2021
Article
Parameswaran Venugopal, MD, discussed the toxicity profiles of BTK inhibitors regarding treatment selection in CLL.
BTK Combos Seek to Raise the Bar in CLL Treatment Paradigm
January 27, 2021
Article
Tara Graff, DO, highlights active areas of exploration that are generating excitement in chronic lymphocytic leukemia.
BTK Inhibitor Combos Could Transform the Complex CLL Armamentarium
November 18, 2020
Article
Alan P. Z. Skarbnik, MD, breaks down factors that should be kept in mind when navigating the complex chronic lymphocytic leukemia armamentarium as it relates to BTK inhibitors.
Dr. Awan on the Importance of Risk Stratification in CLL
November 17, 2020
Video
Farrukh Awan, MD, discusses the importance of risk stratification in chronic lymphocytic leukemia.
Novel Agents Capture Attention in Newly Diagnosed CLL/SLL
November 17, 2020
Article
Matthew Lunning, DO, discussed other key considerations for choosing treatments, continuous vs fixed-duration therapies, and emerging agents for patients with relapsed/ refractory CLL and SLL.
Dr. Lunning on Initial Treatment Considerations in CLL
November 10, 2020
Video
Matthew A. Lunning, DO, discusses initial treatment considerations in chronic lymphocytic leukemia.
Dr. Danilov on the Role of Disease Biology in Up-front Treatment Selection in CLL
November 10, 2020
Video
Alexey V. Danilov, MD, PhD, discusses the role of disease biology in up-front treatment selection in chronic lymphocytic leukemia.
Treatment Selection in CLL Broadens Beyond Discussions of Efficacy
November 09, 2020
Article
Alexey V. Danilov, MD, PhD, discusses BTK inhibitors and BCL-2 inhibitors that have led to a paradigm shift in the treatment of patients with chronic lymphocytic leukemia.
Dr. Awan on the Importance of Collaborative Care in CLL
November 04, 2020
Video
Farrukh Awan, MD, discusses the importance of collaborative care in chronic lymphocytic leukemia.
Dr. Danilov on the Role of Chemoimmunotherapy in CLL
October 26, 2020
Video
Alexey V. Danilov, MD, PhD, discusses the role of chemoimmunotherapy in chronic lymphocytic leukemia.
Dr. Awan on Treatment Options in the First Relapsed Setting of CLL
October 23, 2020
Video
Farrukh Awan, MD, discusses treatment options in the first relapsed setting in patients with chronic lymphocytic leukemia.